Trials / Completed
CompletedNCT03629392
Methionine and Cysteine Restriction in Humans
Dietary Methionine and Cysteine Restriction in Overweight Human Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- University of Oslo · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to examine the effect of methionine and cysteine restriction on energy and macronutrient metabolism in overweight human subjects
Detailed description
The sulfur-containing amino acid methionine and its downstream metabolite cysteine has been associated with fat mass in animal studies and human observational studies. Some of the proposed mechanisms include an association with lipogenesis, insulin sensitivity and disrupted energy metabolism. The overall aim of this project is to evaluate the effects of a diet low in methionine and cysteine on markers of lipids, amino acids, glucose and other biomarkers related to energy metabolism, including transcriptomic and protein expression data from adipose tissue and lymphocytes. Overweight and obese but otherwise healthy volunteers will be randomized to receive a diet either low, moderate or high in methionine and cysteine concentrations for 1 week. This is a pilot study that may be considered an extension of NCT02647970. In addition to the primary and secondary outcomes we will evaluate the feasibility of the intervention and procedures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Low met/cys diet | Dietary intervention with low contents of methionine and cysteine |
| BEHAVIORAL | Moderate met/cys diet | Dietary intervention with moderate contents of methionine and cysteine |
| BEHAVIORAL | High met/cys diet | Dietary intervention with high contents of methionine and cysteine |
Timeline
- Start date
- 2018-10-08
- Primary completion
- 2018-12-11
- Completion
- 2018-12-11
- First posted
- 2018-08-14
- Last updated
- 2020-03-25
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT03629392. Inclusion in this directory is not an endorsement.